Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Tarek Assi

Showing results (71-80 of 120) with videos related to

Pageof 12
Sort By:
Journal of the Egyptian National Cancer Institute|June 26, 2022
Sarcoma of unknown primary: myth or reality?Elie Rassy, Rosy Abou-Jaoude, Stergios Boussios, et al.
Critical Reviews in Oncology/Hematology|December 5, 2017
The Therapeutic use of human albumin in cancer patients' managementElissar Moujaess, May Fakhoury, Tarek Assi, et al.
Asian Pacific Journal of Cancer Prevention : APJCP|April 30, 2015
Distribution of testicular tumors in Lebanon: a single institution overviewTarek Assi, Marc Rassy, Hussein Nassereddine, et al.
Journal of Geriatric Oncology|September 8, 2017
Geriatric cancer trends in the Middle-East: Findings from Lebanese cancer projections until 2025Fady Gh Haddad, Joseph Kattan, Hampig R Kourie, et al.
Clinics and Research in Hepatology and Gastroenterology|November 14, 2015
Pancreatic small cell cancerElie El Rassy, Samer Tabchi, Hampig Raphael Kourie, et al.
Frontiers in Oncology|July 29, 2020
Screening Strategies for COVID-19 in Patients With Hematologic MalignanciesTarek Assi, Bachar Samra, Laurent Dercle, et al.
Cancer Epidemiology|October 12, 2021
The outcome of patients with serous papillary peritoneal cancer, fallopian tube cancer, and epithelial ovarian cancer by treatment eras: 27 years data from the SEER registryNicholas Pavlidis, Elie Rassy, Jan B Vermorken, et al.
Cancer Treatment Reviews|November 24, 2018
A comprehensive review of the current evidence for trabectedin in advanced myxoid liposarcomaTarek Assi, Joseph Kattan, Elie El Rassy, et al.
Immunotherapy|March 23, 2018
A network meta-analysis of the PD(L)-1 inhibitors in the salvage treatment of urothelial bladder cancerElie El Rassy, Ziad Bakouny, Fouad Aoun, et al.
Future Oncology (London, England)|May 16, 2020
The management of patients with metastatic prostate cancer during the COVID-19 pandemicTarek Assi, Nathalie Ibrahim, Rita-Maria K Abboud, et al.
Pageof 12

Showing results (71-80 of 120) with videos related to

Sort By:
Pageof 12
Journal of the Egyptian National Cancer Institute|June 26, 2022
Sarcoma of unknown primary: myth or reality?Elie Rassy, Rosy Abou-Jaoude, Stergios Boussios, et al.
Critical Reviews in Oncology/Hematology|December 5, 2017
The Therapeutic use of human albumin in cancer patients' managementElissar Moujaess, May Fakhoury, Tarek Assi, et al.
Asian Pacific Journal of Cancer Prevention : APJCP|April 30, 2015
Distribution of testicular tumors in Lebanon: a single institution overviewTarek Assi, Marc Rassy, Hussein Nassereddine, et al.
Journal of Geriatric Oncology|September 8, 2017
Geriatric cancer trends in the Middle-East: Findings from Lebanese cancer projections until 2025Fady Gh Haddad, Joseph Kattan, Hampig R Kourie, et al.
Clinics and Research in Hepatology and Gastroenterology|November 14, 2015
Pancreatic small cell cancerElie El Rassy, Samer Tabchi, Hampig Raphael Kourie, et al.
Frontiers in Oncology|July 29, 2020
Screening Strategies for COVID-19 in Patients With Hematologic MalignanciesTarek Assi, Bachar Samra, Laurent Dercle, et al.
Cancer Epidemiology|October 12, 2021
The outcome of patients with serous papillary peritoneal cancer, fallopian tube cancer, and epithelial ovarian cancer by treatment eras: 27 years data from the SEER registryNicholas Pavlidis, Elie Rassy, Jan B Vermorken, et al.
Cancer Treatment Reviews|November 24, 2018
A comprehensive review of the current evidence for trabectedin in advanced myxoid liposarcomaTarek Assi, Joseph Kattan, Elie El Rassy, et al.
Immunotherapy|March 23, 2018
A network meta-analysis of the PD(L)-1 inhibitors in the salvage treatment of urothelial bladder cancerElie El Rassy, Ziad Bakouny, Fouad Aoun, et al.
Future Oncology (London, England)|May 16, 2020
The management of patients with metastatic prostate cancer during the COVID-19 pandemicTarek Assi, Nathalie Ibrahim, Rita-Maria K Abboud, et al.
Pageof 12